Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perfluorohexyloctane for Antiglaucoma Drug-Related Dry Eye
ChiCTR2500114885Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University Eye Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of perfluorohexyloctane in dry eye syndrome (DED), sponsored by Tianjin Medical University Eye Hospital. Primary endpoint: Total Corneal Fluorescein Staining Score. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
perfluorohexyloctane
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2500114885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114885.